Tenderwize
Zurück zur Suche

Framework agreement for Aflibercept supply

AZ Sint-Lucas vzw·Brugge, Belgium·EUR 5.8M·Expired · Jul 31, 2026·Open·Supplies·Framework
High valueStructured notice only
Originaltitel der Bekanntmachung

Belgium – Various medicinal products – Raamovereenkomst voor de levering van Aflibercept

65/100

Opportunity Score

Needs reviewMedium complexity
SuppliesFrameworkExpired
Warum diese Bewertung?

Chance

65 / 100

Komplexität

60 / 100

Risikofaktoren

Lot 1 requires Creditsafe score A, B, or C. Bidders without a good financial score will be excluded. The buyer checks t...

Lot 2 requires a valid FAGG license for distribution. Bidders without this license cannot bid on Lot 2.

Tiefe Portfolioanalyse

Tiefe Analyse der Unternehmenspassung

Verwendet:

  • Description
  • Industries & Services
  • Capabilities
  • Market & Experience
  • Certifications

Eckdaten der Ausschreibung

Öffentlicher Auftraggeber
AZ Sint-Lucas vzw
Land
Belgien
CPV
33690000 - Various medicinal products
Frist
Jul 31, 2026
Geschätzter Wert
EUR 5.8M

Überblick

Moderate opportunity

Wichtige Fakten

  • EUR 5.8M estimated value
  • Framework procurement
  • Supplies contract
  • 3 lots
  • Duration until Sep 2030
  • Supply of Aflibercept (40mg/1ml) medicinal products in two forms: prefilled syringes and vials.
  • Three lots corresponding to different product forms and therapeutic indications.
Vollständige Zusammenfassung anzeigen

This is an open tender from AZ Sint-Lucas vzw in Belgium for the supply of Aflibercept (40mg/1ml) medicinal product. It is divided into three lots: Lot 1 covers prefilled syringes for multiple ophthalmic indications, Lot 2 covers prefilled syringes for retinopathy of prematurity (ROP), and Lot 3 covers vials. Each lot is a framework agreement with a 2-year initial term and two silent 1-year extensions. The total maximum framework value across all lots is EUR 5,803,284 (from XML notice). Award is based primarily on price (82-87%) with quality subcriteria. Electronic submission is required through publicprocurement.be. The tender language is Dutch only. Key risks include short submission window, strict eligibility criteria (financial standing, FAGG license, ESPD), and potential inconsistencies in EU funding status. Procurement documents were not analyzed.

Risiken

Lot 1 requires Creditsafe score A, B, or C. Bidders without a good financial score will be excluded. The buyer checks t...

Lot 2 requires a valid FAGG license for distribution. Bidders without this license cannot bid on Lot 2.

Analyse kann unvollständig sein

Nur ein Teil der Vergabeunterlagen wurde analysiert. Weitere Anforderungen, Zertifikate oder Einreichungsdokumente können in den übrigen Unterlagen enthalten sein.

Wichtige Anforderungen

Administrative

  • Submission language: Dutch only.
  • Electronic submission via publicprocurement.be is mandatory.
  • Bidders can submit for up to 3 lots.

Anforderungen können unvollständig sein.

Zuschlagskriterien

Lot 1

Price (82%) — 82%Flexibility of storage conditions (8%) — 8%Ease of use and safety (5%) — 5%Production place (5%) — 5%

Lot 2

Price (82%) — 82%Flexibility of storage conditions (8%) — 8%Ease of use and safety (5%) — 5%Production place (5%) — 5%

Lot 3

Price (87%) — 87%Flexibility of storage conditions (8%) — 8%Production place (5%) — 5%

Auftraggeber

Ort

Brugge, BEL

Auftraggeberprofil

Profil öffnen

Kennung

408.116.216

Tätigkeit

Health

Lose (3)

LOT-0001

Aflibercept Pre-filled Syringe – Multiple Indications

Supply of Aflibercept (40mg/1ml) prefilled syringe registered for: neovascular age-related macular degeneration, visual impairment due to macular edema secondary to retinal vein occlusion, diabetic macular edema, and myopic choroidal neovascularization.

SuppliesFrameworkEU fundedElectronic submission

EUR 5.7M

Geschätzter Wert

Ort

Brugge, Belgium

Dauer

Sep 2026 - Sep 2030

Kategorie

Medicinal products

Zuschlagskriterien

Price

Frist

Expired Jul 31, 2026

LOT-0002

Aflibercept Pre-filled Syringe – ROP

Supply of Aflibercept (40mg/1ml) prefilled syringe registered for the treatment of retinopathy of prematurity (ROP).

SuppliesFrameworkEU fundedElectronic submission

EUR 8.5k

Geschätzter Wert

Ort

Brugge, Belgium

Dauer

Sep 2026 - Sep 2030

Kategorie

Medicinal products

Zuschlagskriterien

Price

Frist

Expired Jul 31, 2026

LOT-0003

Aflibercept Vial

Supply of Aflibercept (40mg/1ml) in vial form.

SuppliesFrameworkEU fundedElectronic submission

EUR 98.4k

Geschätzter Wert

Ort

Brugge, Belgium

Dauer

Sep 2026 - Sep 2030

Kategorie

Medicinal products

Zuschlagskriterien

Price

Frist

Expired Jul 31, 2026

Vergabedetails

Veröffentlichungsdatum
01 Jul 2026
Sprachen
Dutch

Referenzmetadaten

Rechtsgrundlage
32014L0024

Referenz-IDs

Ausschreibungs-ID
455937-2026

Dokumente (2)

Ähnliche Ausschreibungen